ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Respironics (MM)

Respironics (MM) (RESP)

65.96
0.00
(0.00%)
At close: 13 November 8:00AM
65.96
0.00
( 0.00% )

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
65.96
Bid
0.00
Offer
0.00
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
65.96
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

RESP Latest News

Masimo Expands Its Board of Directors With Appointment of Medical Device Executive Craig Reynolds

Masimo Expands Its Board of Directors With Appointment of Medical Device Executive Craig Reynolds IRVINE, CA--(Marketwired - Apr 4, 2014) - Masimo (NASDAQ: MASI), a global innovator of...

QED International Associates Announces Changes to the HealthShares(TM) Composite and HealthShares(TM) Respiratory/Pulmonary Inde

NEW YORK, March 6 /PRNewswire/ -- QED International Associates, Inc, administrator for the HealthShares(TM) Indexes, a series of 20 underlying indexes for the HealthShares(TM) Exchange-Traded...

Respironics Reports Record Financial Results for Fiscal Year 2008 Second Quarter, Comments on Previously Announced Merger Agreem

MURRYSVILLE, Pa., Jan. 24 /PRNewswire-FirstCall/ -- RESPIRONICS, INC. (NASDAQ:RESP) today announced record financial results for the three months and six months ended December 31, 2007...

Featured Stocks on Today's Edition of the Analyst's Review: RESP, RMD, IVC, SYK

NEW YORK, Dec. 26 /PRNewswire/ -- The Analyst's Review is a daily podcast hosted by WallSt.net editor, Henry Truc that airs every morning at 9 a.m. EST on http://radio.wallst.net/profile.asp?id=1...

Royal Philips Electronics to Acquire Respironics for USD $66.00 Per Share

MURRYSVILLE, Pa., Dec. 21 /PRNewswire-FirstCall/ -- RESPIRONICS, INC. (NASDAQ:RESP) today announced it has entered into a definitive merger agreement pursuant to which Royal Philips Electronics...

Respironics Reports Record Financial Results for Fiscal Year 2008 First Quarter, Achieves 20 Percent Global Sleep Therapy Revenu

MURRYSVILLE, Pa., Oct. 25 /PRNewswire-FirstCall/ -- RESPIRONICS, INC. (NASDAQ:RESP) today announced record financial results for the three months ended September 30, 2007. FINANCIAL RESULTS...

Respironics to Webcast Fiscal 2008 First Quarter Conference Call

MURRYSVILLE, Penn., Oct. 17 /PRNewswire-FirstCall/ -- Respironics, Inc. (NASDAQ:RESP), a recognized resource in the medical device market, announced today that it intends to release its first...

Dixtal Medical Purchases Novametrix Pulse Oximetry Business from Respironics

MURRYSVILLE, Pa., Oct. 8 /PRNewswire-FirstCall/ -- Dixtal Medical, Inc. and Respironics, Inc. (NASDAQ:RESP) announced today that Dixtal Medical has acquired the Novametrix pulse oximetry product...

Respironics Acquires Apollo Light Systems, Inc., Expands into Circadian Rhythm Device-Based Therapy Market

MURRYSVILLE, Pa., Oct. 2 /PRNewswire/ -- Respironics, Inc. (NASDAQ:RESP) today announced that it has acquired 100% of the outstanding shares of Apollo Light Systems, Inc., a 20-year-old...

Respironics Reports Record Financial Results for Fiscal Year 2007 Fourth Quarter and Full Year, Achieves 21 Percent Global Sleep

MURRYSVILLE, Pa., July 25 /PRNewswire-FirstCall/ -- RESPIRONICS, INC. (NASDAQ:RESP) today announced record financial results for the three months and fiscal year ended June 30, 2007...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MVSTMicrovast Holdings Inc
US$ 0.29
(60.49%)
8.57M
NMHINatures Miracle Holding Inc
US$ 0.11
(28.35%)
6.78M
DAVEDave Inc
US$ 79.17
(26.07%)
45.55k
RKLBRocket Lab USA Inc
US$ 18.10
(23.47%)
7.49M
CYCCCyclacel Pharmaceuticals Inc
US$ 0.495
(20.73%)
2.66M
SYRSSyros Pharmaceuticals Inc
US$ 0.3885
(-85.77%)
9.19M
VINOGaucho Group Holdings Inc
US$ 2.32
(-47.87%)
173.64k
VRMVroom Inc
US$ 5.42
(-38.90%)
47.45k
SIBNSI BONE Inc
US$ 11.50
(-26.42%)
4.8k
INSGInseego Corporation
US$ 13.69
(-24.61%)
36.56k
JGLOJP Morgan Global Select Equity ETF
US$ 63.13
(0.00%)
18.88M
SOUNSoundHound AI Inc
US$ 6.93
(-8.33%)
12.51M
LGMKLogicMark Inc
US$ 0.1657
(-7.17%)
9.49M
SYRSSyros Pharmaceuticals Inc
US$ 0.3885
(-85.77%)
9.19M
MVSTMicrovast Holdings Inc
US$ 0.29
(60.49%)
8.57M

Discussion

View Full Feed
The_Gman The_Gman 4 minutes ago
Space. The difference between witnessing a kid napping....and a kidnapping.

Yeah, that's where the pic came from.
NB
ignatiusrielly35 ignatiusrielly35 4 minutes ago
You have no information as to when specifically the ATM is used. Period. In fact, I recall you attributing a price dip earlier this year to dilution in one quarter and the 10q showed virtually none. I repeat, blind guess.
AVXL
12yearplan 12yearplan 4 minutes ago
Sorry for the late reply; .. from your two links and thanks..
 
Summary.
 
Since the early 1970s, hourly inflation-adjusted wages received by the typical worker have barely risen, growing only 0.2% per year. Assigning relative responsibility to the policies and economic f
navycmdr navycmdr 4 minutes ago
https://x.com/InvestIt3/status/1856406733754708460
FNMA
2B_unknown 2B_unknown 4 minutes ago
Yes, we have had the golden ticket for some time now:)

We got this thing, just a matter of time.
NWBO
Hosai Hosai 5 minutes ago
From what I can see based on historical EMA review start dates in late 22 and 23 and aided by chat GPT it guesses the last 2 EMA review start dates for 2024 will be Nov 28th and Dec 27th.
If Anavex were to be aiming for the Nov 28th (ish) it would need to submit any time now. Obv though even
AVXL
MartinLutherKing MartinLutherKing 5 minutes ago
It just hit the wires brother
https://www.forbes.com/sites/jessicaourisman/2024/11/12/the-firsthand-results-of-a-nanofat-treatment-using-stem-cells-and-prp/
ELAB
manibiotech manibiotech 5 minutes ago
Yep nothing for market to be in any FOMO mode 
Likely will slowly go down over next few days without news . As I also said after ASM
ASM
Groveman1 Groveman1 5 minutes ago
Lucky, There's a new response on StockRunners twitter site today 11/12/24 on LLBO. Please check it and see if you can understand what this means for LLBO. StockRunners talks about attorneys and filing papers, but seems to be speaking about the other Company attached to the Post. Check it out.
LLBO
FeMike FeMike 6 minutes ago
I think they would rather say the inspection is completed even if the 10-q is up to September 30 only. If it's done by now since the q was prepared this nov. Therefore, it is not completed up to now.

My personal opinion is that saying "the inspections have been completed" is a bit too
NWBO
cottonisking cottonisking 6 minutes ago
No, peanuts and small money, compared to this board waiting here since 2008 and going through United States' Presidents and nut cases. Shut this mental ward down now. These guys have nothing better to do. Most must be in their 80s.
LEHNQ
northam43 northam43 6 minutes ago
Report #2 October 2024 SPX Cycles

https://investorshub.advfn.com/uimage/uploads/2024/11/12/inz[o2_Completed_Cycles.PNG
manibiotech manibiotech 7 minutes ago
Look at section subsequent events in 10 q

Hmm
NWBO
jimr1717 jimr1717 7 minutes ago
New Tesla Involved in a Crash While on FSD, the Teslacam Footage Was All Police Needed
3 Nov 2024, 22:00 UTC •

Bob claims that the moment the pickup truck slammed into his rear end, the FSD turned the steering wheel to the left to prevent his Tesla from hitting the vehicle wait
TSLA
MRJ25 MRJ25 7 minutes ago
Reddit will be better.
FNMA
Rebel13 Rebel13 7 minutes ago
There’s a saying about not being able to find your a$$ even if handed to you. Didn’t realize you were real!
ELTP
art2426 art2426 8 minutes ago
We're not getting into politics? Really? Who exactly brought THIS up? ---- "Especially with the new pro small business President we just elected!"


How is reading this board, NOT FUN?
BIEL
jimr1717 jimr1717 8 minutes ago
How? Watch and learn.
TSLA
mrwrn2010 mrwrn2010 9 minutes ago
Blast from the past!
ELTP
Mactheriverrat Mactheriverrat 9 minutes ago
Thoughts on TLRY?
TLRY
exwannabe exwannabe 9 minutes ago
Reimbursement. The Company has evaluated and selected specialized, highly experienced consultants with whom to undertake preparations for a potential reimbursement review ...
In other words, not even close to submitting the evidence that kicks off the NICE process.
NWBO
gdog gdog 9 minutes ago
11-12 buy/cover EVH $14.19 + 4.15%
MahinAgency MahinAgency 10 minutes ago
H.C. Wainwright maintains a "Buy" rating for Cardiol Therapeutics with a price target of $9.00.

MAVERIC-2 trial aims to assess CardiolRx in recurrent pericarditis patients post-IL-1 blocker therapy.
CRDL
againstallodds againstallodds 10 minutes ago
Market expects gold delivery, imagine if no delivery

No gold = no created value
NBRI
CommodityCoverage CommodityCoverage 10 minutes ago
Developing therapeutic compounds for pediatric diseases with unmet medical needs and a large addressable market, clinical-stage biotech company Thiogenesis Therapeutics (TTI.v), recently announced the approval of its European patent for the treatment of Cysteamine Sensitive Disorders, a medical cond
TTI

Your Recent History

Delayed Upgrade Clock